In this episode of the EarliPoint Exchange, hosts Dr. Cheryl Tierney and Kirsten Yurich, BCBA, are joined by autism science advocate Alison Singer, founder of the Autism Science Foundation, for a conversation at the intersection of science, advocacy, and early detection.
Dr. Singer explores the persistent bottlenecks in autism identification, the real-world consequences of delayed diagnosis, and the role of advocacy in shaping research priorities and access to care. The discussion highlights how advances in developmental neuroscience and objective diagnostic technologies are reshaping the landscape of early autism detection. Dr. Singer shares perspectives on how scientific integrity, public policy, and innovative tools can work together to improve outcomes for children and families.
The webinar will be held on April 28th, from 12PM-1PM, and includes 1 BACB Learning CEU. Attendance is included free with a BehaviorLive subscription, and registrants will also have access to the recorded session on-demand for CEUs.
Learning Objectives
- Explain the current systemic bottlenecks that delay autism identification and access to care, and describe their impact on families and long-term outcomes.
- Discuss the role of scientific advocacy and early detection tools in reshaping autism care systems and improving access to evidence-based intervention.
- Evaluate how emerging diagnostic technologies like EarliPoint can integrate with advocacy and research efforts to support earlier, more equitable autism identification.
Register now to reserve your spot and explore how groundbreaking research in eye-tracking is advancing the future of autism diagnosis and assessment.
